IMR Press / CEOG / Volume 50 / Issue 10 / DOI: 10.31083/j.ceog5010203
Open Access Systematic Review
Social Factors and the Risk of Postpartum Depression during the COVID-19 Pandemic: A Systematic Review
Show Less
1 West China School of Medicine, Sichuan University, 610041 Chengdu, Sichuan, China
2 Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, 610041 Chengdu, Sichuan, China
*Correspondence: zhaojt@scu.edu.cn (Jitong Zhao)
These authors contributed equally.
Clin. Exp. Obstet. Gynecol. 2023, 50(10), 203; https://doi.org/10.31083/j.ceog5010203
Submitted: 15 June 2023 | Revised: 15 July 2023 | Accepted: 31 July 2023 | Published: 9 October 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: To investigate the effects of social factors including social support and social restriction on postpartum depression (PPD) during the COVID-19 pandemic. Methods: We conducted a systematic review with PubMed and Web of Science from 1 January 2020 to 1 April 2023. Articles focusing on social factors and PPD during COVID-19 pandemic were investigated. Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale were used to evaluate quality of literatures. Results: We included 31 articles (22 cross-sectional studies and 9 cohort studies) with good quality. Edinburgh Postnatal Depression Scale (EPDS) was used as the preferred measure for defining PPD. Social support reduced the prevalence of developing PPD by 30%–40%. Social restriction increased the risk of PPD but there was lack of evidence or effective scales to define restriction. Conclusions: We found that social support acted as an important protective factor for PPD during the COVID-19 pandemic and that social restriction increased the risk of PPD. EPDS may be an optimal choice for researchers to define PPD. Obstetricians should underline social factors for both pregnancy women and their families. The study was registered on PROSPERO (https://www.crd.york.ac.uk/prospero/), registration number: CRD42023434485.

Keywords
postpartum depression
social support
social restriction
COVID-19
systematic review
1. Introduction

Postpartum depression (PPD) is a common but underappreciated psychological disease. In developing countries, 19.8% or more women suffered from depression after childbirth; a systematic review of 56 studies from 291 countries/territories showed a relatively high comorbidity rate of 17.7% for PPD [1]. The Diagnostic and Statistical Manual, Revision 4, identifies 4 weeks after birth as a separator for “postnatal morbidity”, while the International Statistical Classification of Diseases and Related Health Problems, Revision 10, classifies mental disorders beginning within 6 weeks after delivery as “puerperal-related” [2]. If not identified, PPD may lead to serious consequences, causing harm to the mother and her family.

Social support is a multidimensional concept which broadly refers to the emotional, instrumental or informational assistance that is received from others [3], and is considered to be one of the most effective protective factors against PPD [4]. During the COVID-19 pandemic, maternal perceived social support varied due to epidemic restrictions or other reasons. Social restriction refers to a measure implemented by a government or organization to limit the mobility and liberties of individuals or groups in response to specific social issues or crise, and has been shown to have a strong correlation with PPD. It affects household income, relationships with family and partners, social support, all having the ability to change the prevalence of PPD [5, 6]. Existing research on social support is well-documented and aligns with the general perception that adequate social support is effective in alleviating symptoms of PPD or reducing the prevalence [7, 8]. However, the effects of social restriction on PPD are still unclear [9, 10, 11].

Thus, the aim of this study was to summarize the relationship between social factors, including social support and social restriction, and PPD during the COVID-19 epidemic. Based on these findings, we aim to provide recommendations to professionals working in related fields to reduce the prevalence of PPD.

2. Materials and Methods

We followed the “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA) statement [12] and our study was registered on PROSPERO (https://www.crd.york.ac.uk/prospero/) on 14 June 2023 with a registration number CRD42023434485.

2.1 Literature Search and Study Selection

We conducted a comprehensive search in PubMed and Web of Science to identify relevant studies published from 1 January 2020 to 1 April 2023. Our search strategy included the following query: (postpartum depression) AND COVID-19 AND (social support OR social isolation OR social restriction OR social lockdown). Two authors independently screened the literature for eligibility. Inclusion criteria was as follows: (1) Postpartum women aged 18 or older; (2) Women without any severe complications such as postpartum hemorrhage, preeclampsia or diabetes; (3) Studies evaluating the relationship between social support or social restriction and PPD; (4) Observation studies including cohort studies, case control studies or cross-sectional studies; and (5) Studies in English. Exclusion criteria was as follows. (1) Review studies; (2) Duplicate records found in database; (3) Unavailable full text or data.

2.2 Quality Assessment

Two authors evaluated the quality of included studies with the Newcastle-Ottawa Scale (NOS) [13] for cohort studies and case-control studies, and the Agency for Healthcare Research and Quality Scale (AHRQS) [14] for cross-sectional studies. With NOS, studies receiving 5 or more scores were considered good quality (total score 9). With AHRQS, studies receiving 6 or more scores were considered good quality (total score 11).

2.3 Data Extraction

Two authors extracted the following information from eligible studies: name of first author, publication date, study region, social factors, sample size, prevalence of PPD and scales on PPD. Main outcome of our study was prevalence or risk of PPD.

2.4 Strategy for Data Synthesis

Since prevalence studies tend to be highly heterogeneous, we did not perform a meta-analysis.

3. Result
3.1 Selection and Quality of Studies

Flow chart of study selection was shown in Fig. 1. The initial literature search yielded 280 records. After removing duplicate publications, we screened the titles and abstracts of 212 papers. We excluded 37 articles that were not directly related to our study. Of the remaining 175 articles, full text of 14 articles was not available. We then applied our exclusion criteria to the 161 available full-text articles. Ultimately, we included 31 articles in our study [5, 6, 7, 8, 9, 10, 11, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38]. The specific details of included studies were presented in Table 1 (Ref. [5, 6, 7, 8, 9, 10, 11, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38]). Among the 31 studies, 9 were cohort studies [11, 21, 22, 27, 28, 31, 32, 36, 38] and 22 were cross-sectional studies [5, 6, 7, 8, 9, 10, 15, 16, 17, 18, 19, 20, 23, 24, 25, 26, 29, 30, 33, 34, 35, 37]. For study quality, we used NOS to assess cohort studies, finding 7 studies with good quality [11, 22, 28, 31, 32, 36, 38], and we used AHRQS to assess cross-sectional studies, finding 22 studies with good quality [5, 6, 7, 8, 9, 10, 15, 16, 17, 18, 19, 20, 23, 24, 25, 26, 29, 30, 33, 34, 35, 37]. The details of study evaluation were presented in Table 2 (Ref. [11, 21, 24, 26, 27, 30, 33, 36, 38]) and Table 3 (Ref. [5, 6, 7, 8, 9, 10, 15, 16, 17, 18, 19, 20, 22, 23, 25, 28, 29, 31, 32, 34, 35, 37]) respectively. Furthermore, the quality results showed that all included studies had a low risk of bias.

Fig. 1.

Flow chart of study selection for inclusion in this systematic review.

Table 1.The basic information of 31 selected studies.
Study Publication date Region(s) Participants PPD/total (n%) Social support Social restriction PPD definition
Spinola et al. [10] 2020 Italy 1057/2403 (44%) EPDS
Lebel et al. [15] 2020 Canada 653/1987 (33%) × EPDS
Christie et al. [16] 2022 Australia NA/139 × DASS-21
Muldoon et al. [17] 2021 Canada 64/216 (30%) EPDS
Kinser et al. [18] 2021 USA NA/524 × BSI
Fallon et al. [19] 2021 UK 24/614 (4%) EPDS
Terada et al. [20] 2021 Japan 35/461 (8%) × EPDS
Gustafsson et al. [24] 2021 USA 175/393 (45%) × CES-D
Fernandes et al. [21] 2022 Portuguese 67/290 (23%) EPDS
Jones et al. [5] 2022 England 268/424 (63%) × EPDS
Clifton et al. [11] 2022 Australia NA/454 DASS-21
Nguyen et al. [22] 2022 Vietnam NA/868 EPDS
Kokkinaki et al. [23] 2022 Greek 6/132 (5%) × EPDS
Goldstein et al. [31] 2023 USA 196/616 (32%) EPDS
Howard et al. [8] 2022 USA 328/601 (55%) × PHQ-9
Lin et al. [25] 2022 USA NA/1912 × EPDS
Lequertier et al. [6] 2022 Australia 581/2640 (22%) EPDS
Gluska et al. [26] 2022 Israel NA/246 × EPDS
Galletta et al. [9] 2022 Brazil 69/184 (38%) EPDS
Manning et al. [27] 2022 Canada 33/98 (34%) × EPDS
Kolker et al. [28] 2022 Canada 14/55 (25%) × DASS-21
Liu et al. [29] 2022 USA NA/429 × CES-D
Meister et al. [30] 2022 German NA/131 EPDS
Brik et al. [33] 2022 Spain 173/536 (32%) × EPDS
Harrison et al. [32] 2022 UK 123/251 (49%) × EPDS
Tsuno et al. [7] 2022 Japan 160/558 (29%) EPDS
Feinberg et al. [34] 2022 California 332/2372 (14%) × PHQ-4
Liu et al. [35] 2022 USA 76/506 (15%) × CES-D
Rabinowitz et al. [36] 2023 USA 24/127 (19%) × DASS-21
Coca et al. [37] 2023 5 areas* 953/3253 (29%) × EPDS
Sacchi et al. [38] 2023 Italy NA/643 × EPDS

PPD, postpartum depression; NA, not available; EPDS, Edinburgh Postnatal Depression Scale; PHQ-9, Patient Health Questionnare-9; PHQ-4, Patient Health Questionnare-4; DASS-21, Depression Anxiety and Stress Scale-21; BSI, Brief Symptom Inventory; CES-D, Center for Epidemiologic Studies- Depression.
* Brazil, South Korea, Taiwan, Thailand, and UK.

Table 2.Quality of included cohort studies with the Newcastle-Ottawa Scale.
Reference Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Total Score
Brik et al. [33] 0 0 1 0 1 1 1 1 5
Fernandes et al. [21] 1 0 1 0 1 1 1 0 5
Rabinowitz et al. [36] 1 0 1 0 2 1 1 0 6
Manning et al. [27] 1 0 1 0 2 1 1 0 6
Meister et al. [30] 0 0 1 0 1 1 1 1 5
Sacchi et al. [38] 1 0 1 0 1 1 1 0 5
Clifton et al. [11] 1 0 1 0 2 1 1 1 7
Gluska et al. [26] 0 0 1 0 0 1 1 1 4
Gustafsson et al. [24] 0 0 1 0 1 1 1 0 4

If the article mentioned one item, it would mark “1” point, otherwise, it would mark “0”. Total score was the summation of Q1-Q8. Studies receiving 5 or more scores were considered good quality. Q1, Representativeness of the exposed cohort; Q2, Selection of the non-exposed cohort; Q3, Ascertainment of exposure; Q4, Demonstration that outcome of interest was not present at start of study; Q5, Comparability of cohorts on the basis of the design or analysis; Q6, Assessment of outcome; Q7, Was follow-up long enough for outcomes to occur; Q8, Adequacy of follow up of cohorts.

Table 3.Quality of included cross-sectional studies with the Agency for Healthcare Research and Quality Scale.
References Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Total score
Christie et al. [16] 1 0 1 1 1 1 1 1 1 1 0 9
Fallon et al. [19] 1 0 1 1 1 1 1 1 1 1 0 9
Feinberg et al. [34] 1 0 1 1 1 1 1 1 1 1 0 9
Goldstein et al. [31] 1 0 1 1 1 1 1 1 1 1 0 9
Howard et al. [8] 1 0 1 1 1 1 1 1 1 1 0 9
Jones et al. [5] 1 0 1 1 0 1 1 0 1 1 0 7
Kinser et al. [18] 1 0 1 1 1 1 1 1 1 1 0 9
Kokkinaki et al. [23] 1 0 1 1 1 1 1 1 1 1 0 9
Kolker et al. [28] 1 0 1 1 1 1 1 0 1 1 0 8
Lequertier et al. [6] 1 0 1 1 1 1 1 1 1 1 0 9
Lin et al. [25] 1 0 1 1 1 1 1 1 1 1 0 9
Liu et al. [29] 1 0 1 1 1 1 1 1 0 1 0 8
Liu et al. [35] 1 0 1 1 1 1 1 1 0 1 0 8
Spinola et al. [10] 1 0 1 1 1 1 1 1 1 1 0 9
Tsuno et al. [7] 1 0 1 1 1 1 1 1 1 1 0 9
Coca et al. [37] 1 0 1 1 1 1 1 1 1 1 0 9
Galletta et al. [9] 1 0 1 1 1 1 1 1 1 1 0 9
Harrison et al. [32] 1 0 1 1 1 0 1 0 1 1 0 7
Lebel et al. [15] 1 0 1 1 1 1 1 1 1 1 0 9
Muldoon et al. [17] 1 0 1 1 1 1 1 1 1 1 0 9
Nguyen et al. [22] 1 1 1 1 1 1 1 0 1 1 0 8
Terada et al. [20] 1 0 1 1 1 1 1 1 1 1 0 9

Q1, Define the source of information (survey, record review); Q2, List inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications; Q3, Indicate time period used for identifying patients; Q4, Indicate whether or not subjects were consecutive if not population-based; Q5, Indicate if evaluators of subjective components of study were masked to other aspects of the status of the participants; Q6, Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements); Q7, Explain any patient exclusions from analysis; Q8, Describe how confounding was assessed and/or controlled; Q9, If applicable, explain how missing data were handled in the analysis; Q10, Summarize patient response rates and completeness of data collection; Q11, Clarify what follow-up, if any, was expected and the percentage of patients for which incomplete data or follow-up was obtained.

3.2 Social Factors and PPD

The outbreak of the COVID-19 pandemic in late 2019 has impacted people’s daily lives, particularly mothers. The reported cases of the COVID-19 epidemic and the resulting social restrictions have significantly increased the psychological burden on mothers and led to a noticeable rise in the prevalence of PPD. Information related to social support or social restriction was shown in Table 1.

3.2.1 Social Support and PPD

The measurements and associations between social support and PPD were shown in Table 4 (Ref. [5, 6, 7, 8, 9, 10, 11, 15, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38]). Most of the literature demonstrated that social support was an important protective factor against PPD. Some articles described social support in general terms without specific categorization [15, 20, 21, 27], while others categorized social support from parents, friends, families and healthcare professionals [7, 23, 32]. Some articles suggested that social support from friends could be more protective than from family members [32]. One article suggested that improved social support could be effective in reducing alcohol and drug abuse [8].

Table 4.Measurements and associations between social support and PPD.
Preference Measurement of social support Social support on PPD
Spinola et al. [10] MSSS P
Lebel et al. [15] SSEQ P
Muldoon et al. [17] Self-made scale P
Kinser et al. [18] Self-made scale P
Fallon et al. [19] MSPSS U
Terada et al. [20] MSPSS P
Gustafsson et al. [24] MOS-SSS P
Fernandes et al. [21] MSPSS P
Nguyen et al. [22] PICSS P
Jones et al. [5] Self-made scale P
Clifton et al. [11] CSI; AQoL-6D U
Kokkinaki et al. [23] FACES IV; MSPSS; U
Lin et al. [25] MSPSS U
Howard et al. [8] ISEL-12; BRFSS P
Gluska et al. [26] MSPSS R
Lequertier et al. [6] MSPSS P
Manning et al. [27] SSEQ P
Galletta et al. [9] Self-made scale P
Kolker et al. [28] MOS-SSS U
Liu et al. [29] MSPSS U
Meister et al. [30] Self-made scale P
Goldstein et al. [31] Self-made scale P
Harrison et al. [32] MSPSS P
Brik et al. [33] MOS-SSS P
Tsuno et al. [7] Self-made scale P
Feinberg et al. [34] MOS-SSS P
Liu et al. [35] T-WSSS P
Rabinowitz et al. [36] MSPSS P
Coca et al. [37] MSSS P
Sacchi et al. [38] MSPSS P

PPD, postpartum depression; U, unclear; R, risk factor; P, protective factor; MSSS, Maternity Social Support Scale; SSEQ, Social Support Effectiveness Questionnaire; MSPSS, Multidimensional Scale of Perceived Social Support; PICSS, Perinatal Infant Care Social Support; AQoL-6D, Assessment of Quality of Life 6D; CSI, Couples Satisfaction Index; FACES IV, Family Adaptability and Cohesion Evaluation Scales IV Package; MOS-SSS, Medical Outcomes Study Social Support Survey; ISEL-12, Interpersonal Support Evaluation List; BRFSS, Colorado Behavioral Risk Factor Surveillance System Violence Screener; T-WSSS, Two-Way Social Support Scale.

Among the included literatures, the prevalence rate of PPD during COVID-19 was between 5.5% to 54.5%. This was in sizeable contrast when compared to the postpartum women delivering before COVID-19. One article compared the data before and after the COVID-19 outbreak [21]. All articles mentioning social support stated that adequate social support can reduce the prevalence rate of PPD. One article demonstrated that those who reported support through positive social interactions were at a 60% decreased risk of PPD (risk ratio (RR) = 0.40, p = 0.04) [28]. Additionally, receiving affectionate support was a possible protective factor against stress (RR = 0.52, p = 0.04) [28].

3.2.2 Social Restriction and PPD

Although social restriction during the COVID-19 pandemic was a prominent feature, few articles explored the role in PPD. The impact of social restriction policies varied across regions, leading to diverse findings in the literatures. The measurements and associations between social restriction and PPD were shown in Table 5 (Ref. [6, 7, 9, 10, 11, 16, 17, 19, 21, 22, 30, 31]). Among the 31 included articles, 12 were primarily focused on social restriction (Table 1). Some articles reported that mothers had experienced fear and concerns about the potential impact of the outbreak on their family members, especially their babies [15, 18, 30]. Additionally, the social restriction policies limited their ability to offline social interactions with friends, leading to increased feelings of isolation [16, 32]. Reduced physical activity had also been reported [15, 28]. Moreover, the financial situation of families was affected to varying degrees by the COVID-19 pandemic, resulting in additional stressors for mothers [5, 17]. Changes in family dynamics, particularly in relationships with partners, was also observed [5, 23, 30]. Two studies mentioned the impact of partner violence on PPD, which could be attributed to changes in family income and relationships resulting from the COVID-19 pandemic [8, 17]. Social distancing may influence maternal PPD levels [19]. In addition, strict COVID-19 related restrictions had a significant impact on improving scores of participants with Edinburgh Postnatal Depression Scale (EPDS) [21]. Some articles emphasized effects of the duration, the number of inmates [39], and the intensity of the social restriction [10]. Other articles highlighted the impact of social restriction on reduced physical activity and limited outings [15, 16], changes in family relationships [5, 23, 30], increased social distance from peers [6], and maternal isolation due to reduced communication [19, 28].

Table 5.Measurements and associations between social restrictions and PPD.
Preference Q1 Q2 Q3 Q4 Q5 Social restrictions on PPD
Spinola et al. [10] R
Christie et al. [16] U
Muldoon et al. [17] R
Fallon et al. [19] R
Nguyen et al. [22] U
Fernandes et al. [21] R
Clifton et al. [11] P
Meister et al. [30] R
Lequertier et al. [6] R
Galletta et al. [9] R
Goldstein et al. [31] R
Tsuno et al. [7] R

PPD, postpartum depression; U, unclear; R, risk factor; P, protective factor; Q1, impact on economy; Q2, impact on family relations; Q3, impact on activities; Q4, impact on information acquisition; Q5, impact on family care.

Other articles described different terminology, such as “social restriction” to indicate restrictions on maternal behavior and life, “social isolation” to emphasize the psychological isolation, and “social lockdown” to highlight the various aspects of maternal life affected by policies in different regions. Overall, most of the included articles concluded that social restriction contributed to an increase in PPD symptoms or prevalence. Subjects in various articles also reported that family economic status, perceived social support, and relationships with family members were affected by the implementation of social restriction policies. However, one article argued that social restriction could reduce maternal anxiety and the prevalence of PPD [11].

3.3 Scales to Evaluate PPD

Our study revealed that the Edinburgh Postnatal Depression Scale (EPDS) was predominantly utilized as the preferred measure for defining PPD, since EPDS was used in 21 articles (Table 1). The Depression Anxiety and Stress Scale-21 (DASS-21) and the Center for Epidemiologic Studies-Depression (CES-D) scale were also identified as common choices (Table 1). For some studies, Patient Health Questionnare-9 (PHQ-9), Patient Health Questionnare-4 (PHQ-4) and Brief Symptom Inventory (BSI) were also used to assess PPD. Unlike social support, there were no specific scales to measure social restriction, resulting in varying descriptions among the articles.

4. Discussion

Social support has been identified as one of the most effective protective factors against PPD. However, the COVID-19 pandemic has further curtailed the social support received by mothers due to factors such as social distancing. Compared to postpartum women who delivered babies before the pandemic, those who delivered during the pandemic were more likely to experience the lack of support from healthcare professionals or family members (10.8% vs. 33.5% or 22.3%, p < 0.001) [7]. Thus, we performed a systematic review to assess the effects of social factors, especially social support and social restriction, on risk of PPD. We included 22 cross-sectional studies and 9 cohort studies with most being of good quality. Our systematic review shows that social support is a protective factor for PPD during the COVID-19 pandemic. This is consistent with the conclusions of previous studies [16, 40, 41, 42]. Our study generally mentioned the role of family relationships in improving PPD [6, 7, 9, 23, 30]. A study from Vietnam demonstrated that support from parents-in-law and relatives played an important role in improving maternal psychological state during the pandemic in some cultures with strong family values [22]. However, Harrison et al. [32] demonstrated that family support was found to have no effect on PPD in postpartum women and emphasized the positive effect of support from friends. Another study suggested that social support could significantly reduce the effects of alcohol use, stress, and drug use on PPD [8]. Additionally, Hahn-Holbrook et al. [43] demonstrated that social support not only directly affected maternal mental health through these aspects but might also indirectly affect the prevalence of PPD by influencing the levels of adrenocorticotropin-releasing hormone. Overall, the degree of PPD is influenced by social factors related to social support from family members, friends, and family economic status. This reminds us of the ways in which the pandemic could damage maternal mental health and provide remedies for finding necessary and effective interventions. Encompassing all the articles, we found that adequate social support reduced the likelihood of developing PPD by 30% to 40%. In addition, social support could be beneficial in alleviating depressive symptoms in women who were already suffering from PPD.

As one of the most striking features of the pandemic, social restrictions have played a substantial role in affecting maternal mental health. Due to the lack of evidence or an effective scale for defining restriction, our studies included social restriction in a variety of forms, including before and post lockdown comparisons, the number of inmates blocked, and the intensity of lockdowns in regions. This may affect how a woman receives support from family members, socializes with friends, maintains relationships with her baby, chooses the way she goes outdoors, receives news information, gets support from health care providers, and accesses medications easily. The studies we included generally considered social restriction to be a risk factor for PPD. A study investigating the psychological impact of social and psychological changes on mothers found that perceived social changes resulting from the introduction of social restriction measures was not associated with an increased risk of depression or anxiety in the mother, highlighting the psychological impact of keeping social distancing as an increased risk factor for PPD [19]. Christie et al. [16] highlighted dietary factors such as fruits and vegetables, as well as the benefits of outdoor exercise in maintaining the mother’s physical mood. It is worth noting that while access to information, such as social media, is an important mean of learning news and communicating during social restrictions, some studies suggested that the presence of social media may have had a negative impact on maternal mental health [9, 18], and there is a study suggesting that babies from mothers with more social network support may be more susceptible to COVID-19 [38]. A study from Japan suggested a possible association between PPD and whether to give birth in the home country [7]. This study highlighted the possible effects on maternal PPD due to loss of maternal autonomy, such as isolation from the infant and inability to breastfeed, as demonstrated in other studies we included [25, 29, 37]. Notably, domestic violence has been shown to be an important risk factor for PPD [44, 45]. One study found that social support did not moderate the impact of domestic violence on PPD [8]. Domestic violence may be an important cause of PPD due to the deterioration of family economic conditions due to reduced household income and increased medication use by partners [43]. This also shows that under the impact of socio-economics during the pandemic, families may face greater survival pressure, which will lead to family conflicts. Therefore, we believe that there is also a risk of PPD in spending increased time with partners during the pandemic, and not all mothers with family members can effectively receive support. We found that the primary psychological effects of the pandemic, such as fear of infection in family members or infants, also significantly affected the prevalence and extent of PPD, which was consistent with previous research [46, 47]. In addition, Gluska et al. [26] had found that as the pandemic progressed, the mental health of women who gave birth during this period continued to deteriorate, which also reminded medical institutions and families to pay attention to the mental health of pregnant patients during the COVID-19 period. Adverse social experiences can damage maternal mental health and may require investigations and increased social media regulation. Finally, it is gratifying to note that in completing this review, we found that with the emergence of the pandemic, research has been a significantly increased on social factors and maternal mental health, especially in 2020. This partly suggests that this issue is being valued more than before the pandemic. These differences can be attributed to the cultural context of different regions and the specific circumstances during the restriction period. While there has been significant research on social support and social restriction as the main factors influencing PPD in the COVID-19 pandemic, it is important to analyze the ways in which they affect the prevalence of PPD in mothers and to draw patterns from these findings in order to provide advice to mothers, their families, and healthcare workers.

For a preferred measure for defining PPD, we may suggest EPDS as the optimal choice as it was used in 21 of the included articles.

It must be acknowledged that this review also has some shortcomings: (1) This review is limited due to the lack of confounding factors or limited adjustment of confounding factors in some included studies; (2) Studies using different scales to define PPD and the level of social support may have influenced the accuracy of our final conclusions; (3) The included studies were all observational studies, and more evidences is needed; (4) We only searched text in English.

5. Conclusion

We found that social support acted as an important protective factor for PPD during the COVID-19 pandemic and that social restriction increased the risk of PPD. EPDS may be the optimal choice for researchers to define PPD. Obstetricians should underline social factors for both pregnancy women and their families.

Availability of Data and Materials

The data that support the findings of this study are available on request from the corresponding author.

Author Contributions

HC: protocol development, data collection, manuscript writing. BF: protocol development, data collection, manuscript writing. YG: data collection, manuscript writing. WL: data collection, manuscript writing. YZ: data collection, manuscript writing. SL: conception, design and manuscript editing. JZ: protocol development, manuscript editing. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This work was supported by Science and Technology Department of Chengdu, Key R&D Support Program (No. 2022-YF05-01551-SN) and Medical Technology Project, Health Commission of Sichuan Province (No. 21PJ051).

Conflict of Interest

The authors declare no conflict of interest.

References
[1]
Upadhyay RP, Chowdhury R, Aslyeh Salehi, Sarkar K, Singh SK, Sinha B, et al. Postpartum depression in India: a systematic review and meta-analysis. Bulletin of the World Health Organization. 2017; 95: 706–717C.
[2]
Lobato G, Moraes CL, Dias AS, Reichenheim ME. Postpartum depression according to time frames and sub-groups: a survey in primary health care settings in Rio de Janeiro, Brazil. Archives of Women’s Mental Health. 2011; 14: 187–193.
[3]
House JS, Umberson D, Landis KR. Structures and Processes of Social Support. Annual Review of Sociology. 1988; 14: 293–318
[4]
Pao C, Guintivano J, Santos H, Meltzer-Brody S. Postpartum depression and social support in a racially and ethnically diverse population of women. Archives of Women’s Mental Health. 2019; 22: 105–114.
[5]
Jones K, Harrison V, Moulds ML, Lazard L. A qualitative analysis of feelings and experiences associated with perinatal distress during the COVID-19 pandemic. BMC Pregnancy and Childbirth. 2022; 22: 572.
[6]
Lequertier B, McLean MA, Kildea S, King S, Keedle H, Gao Y, et al. Perinatal Depression in Australian Women during the COVID-19 Pandemic: The Birth in the Time of COVID-19 (BITTOC) Study. International Journal of Environmental Research and Public Health. 2022; 19: 5062.
[7]
Tsuno K, Okawa S, Matsushima M, Nishi D, Arakawa Y, Tabuchi T. The effect of social restrictions, loss of social support, and loss of maternal autonomy on postpartum depression in 1 to 12-months postpartum women during the COVID-19 pandemic. Journal of Affective Disorders. 2022; 307: 206–214.
[8]
Howard KJ, Leong C, Chambless S, Grigsby TJ, Cordaro M, Perrotte JK, et al. Major Depression in Postpartum Women during the COVID-19 Pandemic: Can Social Support Buffer Psychosocial Risks and Substance Use? International Journal of Environmental Research and Public Health. 2022; 19: 15748.
[9]
Galletta MAK, Oliveira AMDSS, Albertini JGL, Benute GG, Peres SV, Brizot MDL, et al. Postpartum depressive symptoms of Brazilian women during the COVID-19 pandemic measured by the Edinburgh Postnatal Depression Scale. Journal of Affective Disorders. 2022; 296: 577–586.
[10]
Spinola O, Liotti M, Speranza AM, Tambelli R. Effects of COVID-19 Epidemic Lockdown on Postpartum Depressive Symptoms in a Sample of Italian Mothers. Frontiers in Psychiatry. 2020; 11: 589916.
[11]
Clifton VL, Kumar S, Borg D, Rae KM, Boyd RN, Whittingham K, et al. Associations between COVID-19 lockdown and post-lockdown on the mental health of pregnant women, postpartum women and their partners from the Queensland family cohort prospective study. BMC Pregnancy and Childbirth. 2022; 22: 468.
[12]
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine. 2009; 151: 264–9, W64.
[13]
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology. 2010; 25: 603–605.
[14]
Guo Y, Lv Y, Liu X, Wang G. Association between heavy metal mercury in body fluids and tissues and diabetes mellitus: a systematic review and meta-analysis. Annals of Translational Medicine. 2023; 11: 114.
[15]
Lebel C, MacKinnon A, Bagshawe M, Tomfohr-Madsen L, Giesbrecht G. Elevated depression and anxiety symptoms among pregnant individuals during the COVID-19 pandemic. Journal of Affective Disorders. 2020; 277: 5–13
[16]
Christie HE, Beetham K, Stratton E, Francois ME. “Worn-out but happy”: Postpartum Women’s Mental Health and Well-Being During COVID-19 Restrictions in Australia. Frontiers in Global Women’s Health. 2022; 2: 793602.
[17]
Muldoon KA, Denize KM, Talarico R, Boisvert C, Frank O, Harvey ALJ, et al. COVID-19 and perinatal intimate partner violence: a cross-sectional survey of pregnant and postpartum individuals in the early stages of the COVID-19 pandemic. BMJ Open. 2021; 11: e049295.
[18]
Kinser PA, Jallo N, Amstadter AB, Thacker LR, Jones E, Moyer S, et al. Depression, Anxiety, Resilience, and Coping: The Experience of Pregnant and New Mothers During the First Few Months of the COVID-19 Pandemic. Journal of Women’s Health (2002). 2021; 30: 654–664.
[19]
Fallon V, Davies SM, Silverio SA, Jackson L, De Pascalis L, Harrold JA. Psychosocial experiences of postnatal women during the COVID-19 pandemic. A UK-wide study of prevalence rates and risk factors for clinically relevant depression and anxiety. Journal of Psychiatric Research. 2021; 136: 157–166.
[20]
Terada S, Kinjo K, Fukuda Y. The relationship between postpartum depression and social support during the COVID-19 pandemic: A cross-sectional study. The Journal of Obstetrics and Gynaecology Research. 2021; 47: 3524–3531.
[21]
Fernandes J, Tavares I, Bem-Haja P, Barros T, Carrito ML. A Longitudinal Study on Maternal Depressive Symptoms During the COVID-19 Pandemic: The Role of Strict Lockdown Measures and Social Support. International Journal of Public Health. 2022; 67: 1604608.
[22]
Nguyen LH, Nguyen LD, Ninh LT, Nguyen HTT, Nguyen AD, Dam VAT, et al. COVID-19 and delayed antenatal care impaired pregnant women’s quality of life and psychological well-being: What supports should be provided? Evidence from Vietnam. Journal of Affective Disorders. 2022; 298: 119–125.
[23]
Kokkinaki T, Koutra K, Michopoulou O, Anagnostatou N, Chaziraki L, Kokarida P, et al. Giving Birth in Unpredictable Conditions: Association between Parents’ COVID-19 Related Concerns, Family Functioning, Dyadic Coping, Perceived Social Support and Depressive Symptoms. Healthcare (Basel, Switzerland). 2022; 10: 2550.
[24]
Gustafsson HC, Young AS, Doyle O, Nagel BJ, Mackiewicz Seghete K, Nigg JT, et al. Trajectories of perinatal depressive symptoms in the context of the COVID-19 pandemic. Child Development. 2021; 92: e749–e763.
[25]
Lin HC, Zehnah PL, Koire A, Mittal L, Erdei C, Liu CH. Maternal Self-Efficacy Buffers the Effects of COVID-19-Related Experiences on Postpartum Parenting Stress. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN. 2022; 51: 177–194.
[26]
Gluska H, Shiffman N, Mayer Y, Margalit S, Daher R, Elyasyan L, et al. Postpartum Depression in COVID-19 Days: Longitudinal Study of Risk and Protective Factors. Journal of Clinical Medicine. 2022; 11: 3488.
[27]
Manning KY, Long X, Watts D, Tomfohr-Madsen L, Giesbrecht GF, Lebel C. Prenatal Maternal Distress During the COVID-19 Pandemic and Associations with Infant Brain Connectivity. Biological Psychiatry. 2022; 92: 701–708.
[28]
Kolker S, Biringer A, Bytautas J, Kukan S, Carroll J. Psychological Distress and Behavioural Changes in Pregnant and Postpartum Individuals During the COVID-19 Pandemic. Journal of Obstetrics and Gynaecology Canada: JOGC. 2022; 44: 1067–1075.
[29]
Liu CH, Hyun S, Mittal L, Erdei C. Psychological risks to mother-infant bonding during the COVID-19 pandemic. Pediatric Research. 2022; 91: 853–861.
[30]
Meister S, Dreyer EM, Hahn L, Thomann M, Keilmann L, Beyer S, et al. Risk of postpartum depressive symptoms is influenced by psychological burden related to the COVID-19 pandemic and dependent of individual stress coping. Archives of Gynecology and Obstetrics. 2022; 1–12.
[31]
Goldstein E, Brown RL, Lennon RP, Zgierska AE. Latent class analysis of health, social, and behavioral profiles associated with psychological distress among pregnant and postpartum women during the COVID-19 pandemic in the United States. Birth (Berkeley, Calif.). 2023; 50: 407–417.
[32]
Harrison V, Moulds ML, Jones K. Support from friends moderates the relationship between repetitive negative thinking and postnatal wellbeing during COVID-19. Journal of Reproductive and Infant Psychology. 2022; 40: 516–531.
[33]
Brik M, Sandonis M, Horrillo Murillo ER, Monfort Ortiz R, Arteaga Fernandez A, de Arriba M, et al. Social Support and Mental Health in the Postpartum Period in Times of SARS-CoV-2 Pandemic: Spanish Multicentre Cohort Study. International Journal of Environmental Research and Public Health. 2022; 19: 15445.
[34]
Feinberg E, Declercq E, Lee A, Belanoff C. The Relationship between Social Support and Postnatal Anxiety and Depression: Results from the Listening to Mothers in California Survey. Women’s Health Issues: Official Publication of the Jacobs Institute of Women’s Health. 2022; 32: 251–260.
[35]
Liu CH, Koire A, Erdei C, Mittal L. Unexpected changes in birth experiences during the COVID-19 pandemic: Implications for maternal mental health. Archives of Gynecology and Obstetrics. 2022; 306: 687–697.
[36]
Rabinowitz EP, Kutash LA, Richeson AL, Sayer MA, Samii MR, Delahanty DL. Depression, anxiety, and stress in pregnancy and postpartum: A longitudinal study during the COVID-19 pandemic. Midwifery. 2023; 121: 103655.
[37]
Coca KP, Chien LY, Lee EY, Souza ACDP, Hong SA, Chang YS. Factors associated with postpartum depression symptoms among postpartum women in five countries during the COVID-19 pandemic: an online cross-sectional study. BMC Psychiatry. 2023; 23: 171.
[38]
Sacchi C, De Carli P, Gregorini C, Monk C, Simonelli A. In the pandemic from the womb. Prenatal exposure, maternal psychological stress and mental health in association with infant negative affect at 6 months of life. Development and Psychopathology. 2023; 1–11.
[39]
Miranda AR, Scotta AV, Cortez MV, Soria EA. Triggering of postpartum depression and insomnia with cognitive impairment in Argentinian women during the pandemic COVID-19 social isolation in relation to reproductive and health factors. Midwifery. 2021; 102: 103072.
[40]
Dennis CL, Dowswell T. Psychosocial and psychological interventions for preventing postpartum depression. The Cochrane Database of Systematic Reviews. 2013; CD001134.
[41]
Jones E, Coast E. Social relationships and postpartum depression in South Asia: a systematic review. The International Journal of Social Psychiatry. 2013; 59: 690–700.
[42]
Ray KL, Hodnett ED. Caregiver support for postpartum depression. The Cochrane Database of Systematic Reviews. 2001; CD000946.
[43]
Hahn-Holbrook J, Schetter CD, Arora C, Hobel CJ. Placental Corticotropin-Releasing Hormone Mediates the Association Between Prenatal Social Support and Postpartum Depression. Clinical Psychological Science: a Journal of the Association for Psychological Science. 2013; 1: 253–264.
[44]
Beydoun HA, Beydoun MA, Kaufman JS, Lo B, Zonderman AB. Intimate partner violence against adult women and its association with major depressive disorder, depressive symptoms and postpartum depression: a systematic review and meta-analysis. Social Science & Medicine (1982). 2012; 75: 959–975.
[45]
Halim N, Beard J, Mesic A, Patel A, Henderson D, Hibberd P. Intimate partner violence during pregnancy and perinatal mental disorders in low and lower middle income countries: A systematic review of literature, 1990-2017. Clinical Psychology Review. 2018; 66: 117–135.
[46]
Safi-Keykaleh M, Aliakbari F, Safarpour H, Safari M, Tahernejad A, Sheikhbardsiri H, et al. Prevalence of postpartum depression in women amid the COVID-19 pandemic: A systematic review and meta-analysis. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2022; 157: 240–247.
[47]
Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. The Lancet Global Health. 2021; 9: e759–e772.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top